CMS certification 260138
St Lukes Hospital of Kansas City
4401 Wornall Road, Kansas City, MO 64111
St Lukes Hospital of Kansas City has a CMS overall rating of 5 out of 5 stars. 79% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. Emergency patients spend a median of 3 h 46 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,042 completed surveys, 23% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | MO | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 387 visits sampled · US median for EDs of the same volume: 3 h 22 min | 3 h 46 min | 2 h 35 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 33 visits sampled | 7 h 28 min | 4 h 23 min | 4 h 17 min |
| Left before being seen Lower is better · 42,158 patients | 8% | 3% | 2% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 385 patients | 72% | 63% | 65% |
How St Lukes Hospital of Kansas City compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| St Lukes Hospital of Kansas CityThis hospital | 5/5 | 79% | 3 h 46 min | 5 better 1 worse |
| St Joseph Medical CenterSame city | 3/5 | 63% | 2 h 4 min | 2 better |
| Truman Medical Center Hospital HillSame city | 3/5 | 60% | 3 h 44 min | 2 better 1 worse |
| Kansas City VA Medical CenterSame city | 4/5 | 69% | — | 4 better |
| Research Medical CenterSame city | 2/5 | 58% | 1 h 30 min | 2 better 3 worse |
| University Health Lakewood Medical CenterSame city | 4/5 | 67% | 2 h 30 min | 1 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Kansas City.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 3,792 cases | Too few cases | 3% | 3.9% |
| Heart attack 123 cases | Too few cases | 12% | 11.9% |
| Heart failure 393 cases | Too few cases | 9.8% | 11.1% |
| Pneumonia 208 cases | Too few cases | 15.6% | 15.2% |
| Stroke 544 cases | Too few cases | 11.2% | 11.9% |
| COPD 72 cases | Too few cases | 7.8% | 8.6% |
| Heart bypass surgery (CABG) 187 cases | Too few cases | 2.5% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 1.12 likely 0.91 – 1.33 | 1 |
| After hip or knee replacement 45 cases | Too few cases | 4% | 4.1% |
| Deaths after a serious but treatable surgical complication 223 cases | No different | 167.16 per 1,000 likely 127.93 per 1,000 – 206.38 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 7,666 cases | Worse | 1.19 per 1,000 likely 0.72 per 1,000 – 1.66 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 8,249 cases | No different | 0.19 per 1,000 likely 0.01 per 1,000 – 0.36 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 9,047 cases | No different | 0.25 per 1,000 likely 0.07 per 1,000 – 0.43 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 3,004 cases | No different | 2.16 per 1,000 likely 0.98 per 1,000 – 3.33 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,670 cases | No different | 0.88 per 1,000 likely 0 per 1,000 – 1.99 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,650 cases | No different | 9.03 per 1,000 likely 5.79 per 1,000 – 12.27 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 3,579 cases | No different | 4.78 per 1,000 likely 3.23 per 1,000 – 6.33 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,714 cases | No different | 4.09 per 1,000 likely 1.66 per 1,000 – 6.52 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 712 cases | No different | 1.73 per 1,000 likely 0.34 per 1,000 – 3.12 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,092 cases | No different | 1.06 per 1,000 likely 0.25 per 1,000 – 1.87 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.49 likely 0.25 – 0.88 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.39 likely 0.17 – 0.77 | 1 |
| Surgical site infections after colon surgery | Better | 0.14 likely 0.01 – 0.7 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 0.91 likely 0.15 – 2.99 | 1 |
| MRSA bloodstream infections | Better | 0.42 likely 0.16 – 0.94 | 1 |
| C. diff intestinal infections | Better | 0.26 likely 0.15 – 0.41 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 295 cases | Too few cases | 13.5% | 14.4% |
| Readmitted after heart failure 758 cases | Too few cases | 19.9% | 21.3% |
| Readmitted after pneumonia 360 cases | Too few cases | 17.6% | 17.3% |
| Readmitted after COPD 189 cases | Too few cases | 18.6% | 20% |
| Readmitted after heart bypass surgery 167 cases | Too few cases | 11.5% | 11% |
| Readmitted after hip or knee replacement 37 cases | Too few cases | 5.7% | 5.8% |
| Days back in hospital after a heart attack 215 cases | Too few cases | 7.5 days per 100 | — |
| Days back in hospital after heart failure 482 cases | Too few cases | -10.1 days per 100 | — |
| Days back in hospital after pneumonia 227 cases | Too few cases | 26.3 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 962 cases | No different | 13.5 per 1,000 likely 10.3 per 1,000 – 17.6 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 609 cases | No different | 10.4 per 100 likely 8.6 per 100 – 12.5 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 609 cases | No different | 5.7 per 100 likely 4.4 per 100 – 7.2 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 612 cases | No different | 1 likely 0.8 – 1.3 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
488 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 39 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Hospitalist | 82 |
| Nurse Anesthetist, Certified Registered | 39 |
| Anesthesiology | 37 |
| Emergency Medicine | 32 |
| Family | 30 |
| Diagnostic Radiology | 27 |
| Anesthesiologist Assistant | 25 |
| Acute Care | 24 |
| Critical Care Medicine | 22 |
| Neonatal | 18 |
| Physician Assistant | 14 |
| Hematology & Oncology | 10 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $5.2M
- 2020 $17.5M
- 2021 $6M
- 2022 $5.8M
- 2023 $4.5M
- 2024 $7M
- 2025 $7.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Speaking, teaching and other services | $156,727 | 14 |
| Grants | $146,250 | 3 |
| Consulting fees | $23,100 | 2 |
| Debt forgiveness | $1,354 | 3 |
| Medical devices and supplies on long-term loan | $33 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Pfizer INC. | $3.5M | 201 |
| Edwards Lifesciences Corporation | $601,827 | 73 |
| Boston Scientific Corporation | $330,933 | 56 |
| Cochlear Americas | $326,286 | 42 |
| AstraZeneca UK Limited | $198,195 | 4 |
| Abbvie INC. | $189,139 | 41 |
| Vifor (International) Ltd. | $187,921 | 5 |
| AstraZeneca Pharmaceuticals LP | $177,108 | 11 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 1B2 OPENLABEL STUDY OF DISITAMAB VEDOTIN IN COMBINATION WITH OTHER ANTICANCER THERAPIES IN SOLID TUMORS PFIZER INC. | $1.5M |
| A RANDOMIZED DOUBLEBLIND PHASE 3 STUDY OF TUCATINIB OR PLACEBO IN COMBINATION WITH TRASTUZUMAB AND PERTUZUMAB AS MAINTENANCE THERAPY FOR METASTATIC H… PFIZER INC. | $675,287 |
| A PHASE 1B2 OPENLABEL MULTICENTER DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS PHARMACODYNAMICS AND … PFIZER INC. | $473,658 |
| AN INTERVENTIONAL OPENLABEL RANDOMIZED MULTICENTER PHASE 3 STUDY OF PF07220060 PLUS LETROZOLE COMPARED TO CDK46 INHIBITOR PLUS LETROZOLE IN PARTICIPA… PFIZER INC. | $455,138 |
| The PROGRESS Trial – Continued Access 2021-01-CAP Edwards Lifesciences Corporation | $181,499 |
| A pivotal, prospective, open-label, multi-arm, multi-center non-randomized study of safety and effectiveness of cochlear implantation in an expanded … Cochlear Americas | $177,166 |
| CAMBRIA-2 A Phase III, Open-Label, Randomised Study to Assess the Efficacy and Safety of Camizestrant (AZD9833, a Next Generation, Oral Selective Est… AstraZeneca UK Limited | $166,428 |
| An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician s Choice in … Merck Sharp & Dohme LLC | $153,392 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about St Lukes Hospital of Kansas City
Is St Lukes Hospital of Kansas City a good hospital?
St Lukes Hospital of Kansas City has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 5 and worse on 1. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend St Lukes Hospital of Kansas City?
79% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,042 completed HCAHPS surveys.
How long is the wait in the St Lukes Hospital of Kansas City emergency room?
Emergency patients spend a median of 3 h 46 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with high patient volume, like this one, the median is 3 h 22 min. 8% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does St Lukes Hospital of Kansas City receive money from drug and device companies?
Drug and device makers reported $7.1M in payments to St Lukes Hospital of Kansas City for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.